A CDK-related treatment is tested in cells with or without an anti-apoptotic protein. Data: treatment alone gives 70% G1 cells, 30% apoptosis, and 12% S-phase cells; treatment plus anti-apoptotic protein gives 72% G1 cells, 8% apoptosis, and 13% S-phase cells. Which conclusion is best supported?